Global Animal Vaccine Market to Reach US$ 25.1 Billion by 2032, Stimulated by Increasing Demand for Animal-Derived Products

December 28, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Animal Vaccine Market Report by Product (Attenuated vaccines, Inactivated vaccines, Subunit vaccines, Toxoid vaccines, Conjugate vaccines, Recombinant vaccines, DNA vaccines Type), Animal Type (Companion Animal, Livestock Animal), Route of Administration (Subcutaneous, Intramuscular, Intranasal, and Others), and Region 2024-2032,” the global animal vaccine market size reached US$ 13.4 Billion in 2023. Animal vaccines are biological preparations designed to improve the immunity of animals against specific diseases. These vaccines function by stimulating the immune system to recognize the disease agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and combat the pathogen in future encounters. The composition of animal vaccines varies depending on the target disease and animal species. They can include live attenuated organisms, inactivated or killed organisms, or subunits of the pathogen, involving rigorous scientific research and testing to ensure safety and efficacy. Animal vaccines play a critical role in veterinary medicine and animal husbandry, contributing to the health and welfare of both domestic and farm animals. They help control and prevent the spread of infectious diseases, particularly in the agriculture and food production sectors.

Global Animal Vaccine Market Trends:

The increasing prevalence of zoonotic diseases, which are infectious diseases transmittable from animals to humans has heightened awareness about animal health, prompting extensive investment in animal vaccination programs, thereby primarily driving the global market. In addition to this, the flourishing expansion of the livestock sector, driven by rising demand for animal protein, necessitates enhanced disease management in livestock populations to ensure productivity and food safety, strengthening the market growth. Moreover, ongoing advancements in biotechnological research leading to the development of more effective and safer vaccines as well as broadening the range of diseases that can be effectively controlled are aiding in market expansion. At the same time, favorable governmental policies and initiatives promoting animal health and mandating regular vaccinations for certain diseases, are contributing to the market growth. Concurrently, increasing pet ownership across the globe, with a surging number of people adopting pets and showing a willingness to spend on their health and well-being, is boosting the market growth. Besides this, the growing focus on preventive healthcare for animals, supportive initiatives by animal welfare organizations, improved distribution channels, and increasing access to veterinary services are fueling the market growth. Furthermore, the growing international trade of animal products spurring the need for standardized health protocols, including vaccinations, to prevent the spread of diseases across borders is influencing the market growth. Apart from this, the introduction of needle-free injection technologies and oral vaccines making the administration of animal vaccines more efficient and less stressful for animals, are propelling the market forward. Looking forward, the market value is projected to reach US$ 25.1 Billion by 2032, expanding at a CAGR of 7.24% during 2024-2032.

Market Summary:

  • Based on the product, the market has been segmented into attenuated, inactivated, subunit, toxoid, conjugate, recombinant, and DNA vaccines. Currently, attenuated vaccines dominate the market, holding the largest share.
  • On the basis of the animal type, the market has been categorized as companion animal (dogs and cats), and livestock animals (cattle, pigs, sheep, and others). Between these, livestock animals represent the biggest market segment.
  • Based on the route of administration, the market has been classified into subcutaneous, intramuscular, intranasal, and others. Amongst these, the subcutaneous route accounts for the largest market share.
  • On a regional basis, the market has been segregated into North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Presently, North America is the leading market.
  • The competitive landscape of the market has also been examined, with some of the key players being C.H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Elanco Animal Health Incorporated (Eli Lilly and Company), Hester Biosciences Limited, Hipra S.A., Hygieia Biological Laboratories, Merck & Co. Inc., Phibro Animal Health Corporation, Vaxxinova GmbH (EW Group), Virbae, Zoetis Services LLC, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Product
  • Animal Type
  • Route of Administration
  • Region
Products Covered Attenuated vaccines, Inactivated vaccines, Subunit vaccines, Toxoid vaccines, Conjugate vaccines, Recombinant vaccines, and DNA vaccines
Animal Types Covered
  • Companion Animal: Dogs, Cats
  • Livestock Animal: Cattle, Pigs, Sheep, Others
Route of Administrations Covered Subcutaneous, Intramuscular, Intranasal, and Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered C.H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Elanco Animal Health Incorporated (Eli Lilly and Company), Hester Biosciences Limited, Hipra S.A., Hygieia Biological Laboratories, Merck & Co. Inc., Phibro Animal Health Corporation, Vaxxinova GmbH (EW Group), Virbae, and Zoetis Services LLC, etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Animal Vaccine Market to Reach US$ 25.1 Billion by 2032, Stimulated by Increasing Demand for Animal-Derived Products
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More